Jonathan L. Metts

Jonathan L. Metts

Pediatric Hematology Oncology
601 5th Street South, Suite 320
Suite 320
Saint Petersburg, FL 33701

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Journal: JCO oncology practice
Published: July 06, 2026

Comparing chemotherapy-induced nausea and vomiting between young adult vs non-young adult cancer patients.

Comparing chemotherapy-induced nausea and vomiting between young adult vs non-young adult cancer patients.

Journal: JNCI cancer spectrum
Published: April 09, 2026

Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT).

Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT).

Journal: Pediatric blood & cancer
Published: April 09, 2026

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Journal: Pediatric blood & cancer
Published: March 07, 2026

Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov.

Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov.

Journal: Children (Basel, Switzerland)
Published: February 28, 2026

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

Journal: British journal of cancer
Published: February 04, 2026

Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives.

Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives.

Journal: Chinese clinical oncology
Published: November 01, 2025

Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Journal: Pediatric blood & cancer
Published: September 11, 2025

A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.

A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.

Journal: Pediatric blood & cancer
Published: July 29, 2025

Secondary Rhabdomyosarcoma in Children, Adolescents, and Young Adults.

Secondary Rhabdomyosarcoma in Children, Adolescents, and Young Adults.

Journal: Pediatric blood & cancer
Published: June 04, 2025

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, and Other Round Cell Sarcomas.

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, and Other Round Cell Sarcomas.

Journal: Hematology/oncology clinics of North America
Published: May 15, 2025

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 14, 2025
Showing 1-12 of 44

Last Updated: 09/26/2026